MEMedpace MEDP · NASDAQ
$669.20 +2.33% (+$15.24)
- Market cap
- $18.3B
- Enterprise value
- $17.7B
- P/E
- 35.2x
- Forward P/E
- 35.1x
- PEG
- 3.5x
- P/S
- 6.4x
- P/FCF
- 25.4x
- EV/EBITDA
- 28.6x
- ROIC
- 62.2%
- Gross margin
- 29.1%
- Net margin
- 18.2%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -0.9x
- Beta
- 1.18
- Free float
- 81.2%
About the company
Medpace Holdings, Inc. (MEDP) is a global company specializing in clinical research and the development of drugs and medical devices. With over twenty years of experience in the field, Medpace provides comprehensive clinical trial services for pharmaceutical and biotechnology companies. The company is known for its expertise, technological innovation, and commitment to ensuring high-quality and safe pharmaceutical products. Medpace Holdings, Inc. (MEDP) shares could be suitable for investors looking to invest in a company playing a key role in clinical research and the development of drugs and medical devices.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
August James Troendle
Employees
6,500
Headquarters
Cincinnati
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number